- Home
- ADCT vs EVN Comparison
ADCT vs EVN Comparison
Compare ADCT & EVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- EVN
- Stock Information
- Founded
- ADCT 2011
- EVN 1998
- Country
- ADCT Switzerland
- EVN United States
- Employees
- ADCT N/A
- EVN N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- EVN Investment Bankers/Brokers/Service
- Sector
- ADCT Health Care
- EVN Finance
- Exchange
- ADCT Nasdaq
- EVN Nasdaq
- Market Cap
- ADCT 398.2M
- EVN 423.6M
- IPO Year
- ADCT 2020
- EVN N/A
- Fundamental
- Price
- ADCT $3.33
- EVN $10.89
- Analyst Decision
- ADCT Strong Buy
- EVN
- Analyst Count
- ADCT 6
- EVN 0
- Target Price
- ADCT $7.80
- EVN N/A
- AVG Volume (30 Days)
- ADCT 711.4K
- EVN 101.2K
- Earning Date
- ADCT 11-06-2025
- EVN 01-01-0001
- Dividend Yield
- ADCT N/A
- EVN 4.78%
- EPS Growth
- ADCT N/A
- EVN N/A
- EPS
- ADCT N/A
- EVN 0.34
- Revenue
- ADCT $77,246,000.00
- EVN N/A
- Revenue This Year
- ADCT $12.71
- EVN N/A
- Revenue Next Year
- ADCT $6.59
- EVN N/A
- P/E Ratio
- ADCT N/A
- EVN $29.94
- Revenue Growth
- ADCT 15.73
- EVN N/A
- 52 Week Low
- ADCT $1.05
- EVN $8.64
- 52 Week High
- ADCT $3.97
- EVN $10.45
- Technical
- Relative Strength Index (RSI)
- ADCT 56.37
- EVN 71.36
- Support Level
- ADCT $3.04
- EVN $10.39
- Resistance Level
- ADCT $3.59
- EVN $10.48
- Average True Range (ATR)
- ADCT 0.17
- EVN 0.10
- MACD
- ADCT 0.03
- EVN 0.05
- Stochastic Oscillator
- ADCT 55.65
- EVN 92.06
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
About EVN Eaton Vance Municipal Income Trust
Eaton Vance Municipal Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax. The trust's portfolio of investments majorly consists of debt instruments of governments, municipal organizations the interest on which is exempt from regular federal income tax and has also some exposure to corporate bonds and other instruments.